Abeona Therapeutics Inc.
ABEO
$5.34
-$0.07-1.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.46M | -5.16M | 108.83M | -12.03M | -9.29M |
| Total Depreciation and Amortization | 1.09M | 888.00K | 768.00K | 815.00K | 776.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.01M | 111.00K | -144.04M | -3.77M | -4.21M |
| Change in Net Operating Assets | -593.00K | -17.03M | 15.65M | -3.42M | -3.84M |
| Cash from Operations | -17.95M | -21.19M | -18.78M | -18.40M | -16.56M |
| Capital Expenditure | -1.15M | -2.52M | -2.90M | -1.40M | -606.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.71M | -62.11M | 158.79M | 5.61M | 19.48M |
| Cash from Investing | 9.55M | -64.63M | 155.89M | 4.21M | 18.88M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.61M | 5.16M | 10.50M | 6.80M | 5.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -6.00K | -31.00K | -199.00K |
| Cash from Financing | 3.61M | 5.16M | 10.50M | 6.77M | 5.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.79M | -80.65M | 147.60M | -7.42M | 7.63M |